This is a study for patients with advanced cholangiocarcinoma or gallbladder cancer. It includes chemotherapy (gemcitabine and cisplatin) with the addition of a PI3K inhibitor to try to improve outcome for this group of patients

Enrollment

25

Study Start Date

08/01/2016

Estimated Completion Date

03/01/2018

Purpose of the Study – in Layman’s Terms (use the “+” to add more list items)

To improve the outcome for patients with cholangiocarcinoma or gallbladder cancer